TGFB1 and renal fibrosis: In an in vitro study conducted to assess the effect and underlying mechanism of MA’s activity in renal fibrosis, MA downregulated MyD88 and TGF-β/Smad pathways, leading to the decrease of extracellular matrix proteins expression and pro-inflammatory cytokines, thus inhibiting renal fibroblast proliferation [215].